[Corrections] Correction to Lancet Oncol 2024; 25: 1038–52

Allaf ME, Kim S-E, Master V, et al. Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study. Lancet Oncol 2024; 25: 1038–52—In this Article, some of the numbers of patients in the Results and figure 1 have been corrected. The appendix has also been corrected. These corrections have been made to the online version as of Nov 24, 2025.